Clinical trials
Asthma trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 7 |
| 2025 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Unknown status | 9 |
| Recruiting | 8 |
| Terminated | 5 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Montpellier | 8 |
| Assistance Publique - Hôpitaux de Paris | 6 |
| University Hospital, Bordeaux | 6 |
| University Hospital, Strasbourg, France | 4 |
| Hopital Foch | 3 |
| University Hospital, Toulouse | 3 |
| Alyatec | 2 |
| Assistance Publique Hopitaux De Marseille | 2 |
| University Hospital, Brest | 2 |
| University Hospital, Clermont-Ferrand | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 53 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Hypersensitivity | 4 |
| Bronchopulmonary Dysplasia | 2 |
| Disease | 2 |
| Dysbiosis | 2 |
| Lymphoma, Follicular | 2 |
| Airway Obstruction | 1 |
| Airway Remodeling | 1 |
| Angioedema | 1 |
Trials
Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.